Atlas Trials

Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease

Clinical trial NCT06984484 · RECRUITING

Trial details

NCT number
NCT06984484
Sponsor
Devintec Sagl
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease (GERD)
Start date
2025-07-02
Primary completion
2026-06-01
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.